{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:58Z","timestamp":1707524758635},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,18]]},"DOI":"10.7759\/cureus.32657","type":"journal-article","created":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T14:08:34Z","timestamp":1671372514000},"source":"Crossref","is-referenced-by-count":0,"title":["Cephradine-Induced Toxic Epidermal Necrolysis: A Case Report of Treatment With Etanercept"],"prefix":"10.7759","author":[{"given":"Rawan","family":"Hubail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layal","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameen","family":"Al Awadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis: an eruption resembling scalding of the skin","volume":"68","author":"Lyell A","year":"1956","unstructured":"Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956, 68:355-361. 10.1111\/j.1365-2133.1956.tb12766.x","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2016.6.1.43","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013","volume":"6","author":"Suwarsa O","year":"2016","unstructured":"Suwarsa O, Yuwita W, Dharmadji HP, Sutedja E. Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013. Asia Pac Allergy. 2016, 6:43-47. 10.5415\/apallergy.2016.6.1.43","journal-title":"Asia Pac Allergy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijstd.IJSTD_61_19","article-title":"Study of genital manifestations of Stevens Johnson syndrome\/toxic epidermal necrolysis","volume":"43","author":"Gulanikar A","year":"2022","unstructured":"Gulanikar A, Abrol A, Sagar S. Study of genital manifestations of Stevens Johnson syndrome\/toxic epidermal necrolysis. Indian J Sex Transm Dis AIDS. 2022, 43:39-42. 10.4103\/ijstd.IJSTD_61_19","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.9","article-title":"Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding","volume":"55","author":"French LE","year":"2006","unstructured":"French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006, 55:9-16. 10.2332\/allergolint.55.9","journal-title":"Allergol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave TA","year":"2005","unstructured":"Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol. 2005, 153:241-253. 10.1111\/j.1365-2133.2005.06721.x","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.04.044","article-title":"Etanercept therapy for toxic epidermal necrolysis","volume":"71","author":"Paradisi A","year":"2014","unstructured":"Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol. 2014, 71:278-283. 10.1016\/j.jaad.2014.04.044","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cps.2017.02.016","article-title":"Burn center care of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"44","author":"Cartotto R","year":"2017","unstructured":"Cartotto R. Burn center care of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Plast Surg. 2017, 44:583-595. 10.1016\/j.cps.2017.02.016","journal-title":"Clin Plast Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500375684","article-title":"Toxic epidermal necrolysis (TEN) Lyell's syndrome","volume":"16","author":"Sehgal VN","year":"2005","unstructured":"Sehgal VN, Srivastava G. Toxic epidermal necrolysis (TEN) Lyell's syndrome. J Dermatolog Treat. 2005, 16:278-286. 10.1080\/09546630500375684","journal-title":"J Dermatolog Treat"},{"key":"ref9","article-title":"Toxic epidermal necrolysis from a cigarette burn","volume":"11","author":"Parker JR","year":"2010","unstructured":"Parker JR, Berkeley RP. Toxic epidermal necrolysis from a cigarette burn. West J Emerg Med. 2010, 11:205-207.","journal-title":"West J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy E","year":"2015","unstructured":"Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis. J Allergy Clin Immunol. 2015, 135:745-752. 10.1016\/j.jaci.2014.07.062","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S160964","article-title":"A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Ng QX","year":"2018","unstructured":"Ng QX, De Deyn ML, Venkatanarayanan N, Ho CY, Yeo WS. A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Inflamm Res. 2018, 11:135-142. 10.2147\/JIR.S160964","journal-title":"J Inflamm Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.08.004","article-title":"Drug-induced severe cutaneous adverse reactions: determine the cause and prevention","volume":"123","author":"Zhang C","year":"2019","unstructured":"Zhang C, Van DN, Hieu C, Craig T. Drug-induced severe cutaneous adverse reactions: determine the cause and prevention. Ann Allergy Asthma Immunol. 2019, 123:483-487. 10.1016\/j.anai.2019.08.004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.10-RAI-0261","article-title":"Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"59","author":"Chung WH","year":"2010","unstructured":"Chung WH, Hung SI. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010, 59:325-332. 10.2332\/allergolint.10-RAI-0261","journal-title":"Allergol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0462","article-title":"Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis","volume":"88","author":"Wojtkiewicz A","year":"2008","unstructured":"Wojtkiewicz A, Wysocki M, Fortuna J, Chrupek M, Matczuk M, Koltan A. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis. Acta Derm Venereol. 2008, 88:420-421. 10.2340\/00015555-0462","journal-title":"Acta Derm Venereol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang CW","year":"2018","unstructured":"Wang CW, Yang LY, Chen CB, et al.. Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest. 2018, 128:985-996. 10.1172\/JCI93349","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127409-cephradine-induced-toxic-epidermal-necrolysis-a-case-report-of-treatment-with-etanercept","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:44Z","timestamp":1707508004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127409-cephradine-induced-toxic-epidermal-necrolysis-a-case-report-of-treatment-with-etanercept"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.32657","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,18]]}}}